ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.

Yonsei Med J · 2014 · PMC4205709 · PMID 25323906

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study showed a trend toward an increased CI in recurrent disease compared with those in primary disease for most anticancer drugs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.